Home › Long COVID › South Carolina › Charleston
Long COVID clinical trials in Charleston, SC
3 studies for Long COVID are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RecruitingPhase 3
- Medical University of South Carolina Ashley River Tower, Charleston
- Medical University of South Carolina - SCTR Research Nexus, Charleston
- Medical University of South Carolina, Charleston
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- Medical University of South Carolina Infectious Disease Clinic, Charleston
- Medical University of South Carolina Investigational Drug Services (IDS), Charleston
- Medical University of South Carolina Investigational Drug Services Pharmacy, Charleston
- and 3 more
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
RecruitingPhase 2/3
- Medical University of South Carolina, Charleston
About Long COVID
Anyone who has had COVID-19 can have long-lasting symptoms, know as long COVID. Learn about the symptoms and how to manage them, diagnosis, and prevention.
More about Long COVID on MedlinePlus
Long COVID trials in other cities
- New York City, NY17 studies
- Houston, TX14 studies
- Chicago, IL12 studies
- Washington, DC12 studies
- Boston, MA11 studies
- Baltimore, MD11 studies
- Hialeah, FL8 studies
- Durham, NC8 studies
- San Francisco, CA8 studies
- Atlanta, GA7 studies
- San Diego, CA7 studies
- Miami, FL7 studies
Other studies in Charleston
- Stroke19 studies
- Depression18 studies
- Post-Traumatic Stress Disorder16 studies
- Head and Neck Squamous Cell Carcinoma16 studies
- Heart Failure16 studies
- Non-Small Cell Lung Cancer16 studies
- Prostate Cancer16 studies
- Cardiovascular Disease16 studies
- Cancer (all types)14 studies
- Parkinson's Disease13 studies
- Breast Cancer12 studies
- Lung Cancer12 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.